XOMA PEER ANALYSIS

XOMA Royalty Corporation — metric-by-metric comparison with peers and the industry median

XOMAXOMA Royalty Corporation

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

XOMAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	XOMA	MSB	TLX	RTALB	CSL	Ind. Median
P/E	24.24	—	—	4.89●	30.02	17.81
P/B	6.77	—	6.56	0.61●	2.24	3.49
EV/EBITDA	15.82	—	123.31	74.61	10.37●	14.92
P/S	21.08	31.91	3.34	6.67	2.67●	10.89

Financial Health
Metric	XOMA	MSB	TLX	RTALB	CSL	Ind. Median
Current Ratio	3.59●	—	1.43	1.21	2.57	5.90
Debt/Equity	110.5%	—	112.3%	1.2%●	67.4%	10.9%
NetDebt/EBITDA	0.59●	—	13.13	0.90	2.22	1.15

Profitability
Metric	XOMA	MSB	TLX	RTALB	CSL	Ind. Median
Net Margin	87.0%	-115.3%	-0.9%	136.3%●	9.2%	-125.7%
ROE	31.9%●	-11.3%	-1.8%	15.1%	7.7%	-47.5%
ROA	13.0%	-8.6%	-0.7%	13.1%●	3.8%	-35.8%
EBITDA Margin	138.4%●	-76.6%	3.0%	9.0%	32.8%	-105.8%

Growth + Dividend
Metric	XOMA	MSB	TLX	RTALB	CSL	Ind. Median
Rev. Growth	-3.3%	410.4%●	56.3%	24.0%	4.8%	5.1%
NI Growth	—	—	—	134.0%●	-39.4%	12.1%
Div. Yield	0.7%	0.0%	—	0.0%	2.5%●	0.2%
Payout	17.5%	0.0%	—	0.0%	103.1%	0.0%

Valuation
Metric	XOMA	RIGL	ACRS	RGNX	CRMD	PRME	Ind. Median
P/E	24.24	2.18●	—	—	4.52	—	17.81
P/B	6.77	1.98	4.92	36.88	1.87●	9.21	3.49
EV/EBITDA	15.82	5.27	—	—	3.69●	—	14.92
P/S	21.08	2.64	84.52	8.85	2.04●	175.16	10.89

Financial Health
Metric	XOMA	RIGL	ACRS	RGNX	CRMD	PRME	Ind. Median
Current Ratio	3.59	2.62	4.03●	2.62	2.98	3.80	5.90
Debt/Equity	110.5%	11.4%	1.4%●	337.1%	33.2%	149.3%	10.9%
NetDebt/EBITDA	0.59	-0.77●	1.46	0.35	-0.16	0.11	1.15

Profitability
Metric	XOMA	RIGL	ACRS	RGNX	CRMD	PRME	Ind. Median
Net Margin	87.0%	121.5%●	-832.6%	-330.2%	45.2%	-4,917.6%	-125.7%
ROE	31.9%	174.1%●	-48.4%	-196.4%	65.6%	-216.1%	-47.5%
ROA	13.0%	107.0%●	-35.1%	-69.6%	37.5%	-63.7%	-35.8%
EBITDA Margin	138.4%●	43.8%	-843.9%	-261.2%	53.2%	-4,732.2%	-105.8%

Growth + Dividend
Metric	XOMA	RIGL	ACRS	RGNX	CRMD	PRME	Ind. Median
Rev. Growth	-3.3%	47.6%	-52.9%	-44.0%	384.6%●	-90.3%	5.1%
NI Growth	—	879.7%	—	—	953.6%●	—	12.1%
Div. Yield	0.7%	—	—	—	—	—	0.2%
Payout	17.5%	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on XOMA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.